Drug Research
Drug Delivery

Drug Delivery News

View news from other Pharmaceutical sectors:
16-30 of 2323 results
Recipharm to buy remaining stake in Nitin Lifesciences
Recipharm has agreed to acquire the remaining 26% stake in Nitin Lifesciences, which were owned by members of the founding Sobti family.
Drug Research > Drug Delivery > News
Mylan launches Estrace Cream generic after FDA approval
Mylan has launched Estradiol Vaginal Cream USP, 0.01%, the first generic version of Allergan's Estrace Cream, in the US.
Drug Research > Drug Delivery > News
Evox Therapeutics to collaborate with Boehringer Ingelheim on exosome-mediated drug delivery
Evox Therapeutics has entered into a research collaboration with Boehringer Ingelheim to investigate exosome-mediated delivery of RNAs with high medical relevance to targets for specific disease areas of focus to Boehringer Ingelheim.
Drug Research > Drug Delivery > News
NICE says lenvatinib should be available on NHS
The National Institute for Health and Care Excellence (NICE) has announced that lenvatinib should be available on the National Health Service (NHS) to give people with advanced kidney cancer a new treatment option.
Drug Research > Drug Delivery > News
Report expects global cryotherapy market to cross $4bn by 2024
A new report from Persistence Market Research expects worldwide cryotherapy market to exceed $4bn by 2024.
Drug Research > Drug Delivery > News
US FDA approves first drug with digital ingestion tracking system
By PBR Staff Writer
Otsuka Pharmaceutical has secured approval from the US Food and Drug Administration for its Abilify MyCite (aripiprazole tablets with sensor), an antipsychotic drug that has an embedded sensor to digitally track if patients have ingested their medication.
Drug Research > Drug Delivery > News
UK’s NICE makes Nivolumab available for head and neck cancer patients
UK’s National Institute for Health and Care Excellence (NICE) has made nivolumab (Opdivo) made by Bristol-Myers Squibb available for patients with head and neck cancer who did not respond to chemotherapy within six months, and the cancer has spread to other parts of the body.
Drug Research > Drug Delivery > News
FDA advisory panel recommends approval of GSK’s shingles vaccine Shingrix
By PBR Staff Writer
An advisory committee of the US Food and Drug Administration (FDA) has recommended the approval of GlaxoSmithKline’s (GSK) Shingrix vaccine for the prevention of herpes zoster (shingles) in adults aged 50 years and over.
Drug Research > Drug Delivery > News
HitGen, Takeda enter DNA-encoded library based drug discovery research collaboration
HitGen announced that the company has entered into a research collaboration with Takeda Pharmaceutical Company to discover novel small molecule leads for multiple targets in Takeda’s therapeutic areas of interest.
Drug Research > Drug Delivery > News
Mylan Launches Generic Antiretroviral Medicine, Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Canada
Mylan Pharmaceuticals ULC, a subsidiary of Mylan N.V., a leading global pharmaceutical company, announced the launch of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate 600 mg, 200 mg, and 300 mg, a generic alternative to Atripla in Canada.
Drug Research > Drug Delivery > News
Takeda, Cardurion Pharmaceuticals form cardiovascular development partnership
Takeda Pharmaceutical and Cardurion Pharmaceuticals have created a new cardiovascular development partnership.
Drug Research > Drug Delivery > News
Study says machine learning algorithms can help predict schizophrenia
By PBR Staff Writer
A new study has found that artificial intelligence (AI) and machine learning algorithms helped predict instances of schizophrenia with 74% accuracy.
Drug Research > Drug Delivery > News
GlobalData says acute myeloid leukemia market will cross $1.5bn by 2026
The acute myeloid leukemia (AML) market in the seven major countries (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will grow more than three times from $406m in 2016 to more than $1.5bn by 2026, reflecting a compound annual growth rate of 14%, as per research and consulting firm GlobalData.
Drug Research > Drug Delivery > News
Sarepta, BioMarin settle patent litigation over DMD exon-skipping drugs
By PBR Staff Writer
Sarepta Therapeutics and BioMarin Pharmaceutical have settled a global patent litigation relating to the use of the former’s Exondys 51 and all future exon-skipping products for the treatment of Duchenne muscular dystrophy (DMD).
Drug Research > Drug Delivery > News
Sanofi to buy US vaccines biotechnology firm Protein Sciences
By PBR Staff Writer
French drugmaker Sanofi has agreed to acquire US vaccines biotechnology firm Protein Sciences for around $650m.
Drug Research > Drug Delivery > News
16-30 of 2323 results